Member Info for BOJO2020

Looking at first 20 transactions, 17 of these are clearly buys. I know this as I have added 143123 myself and the buy price is correct. So how come its is getting cheaper?

Anyway, .69 looks like base camp to me and my average is .67 so all good.

Seems like a buy to me but something does not add up. I have been adding at these levels (14p) and expect 22 to 24p later this year. By the time it actually starts mining I'd expect 40p.

Am I reading this wrong. I mean, I half expect a low ball offer from Newcrest and SD and a select few of his team to become part of a new department within that company. The holders on that board are so in love with the story that they don't want it to end that way and so are incapable of believing it.

Any thoughts and especially is it a buy???

Not mine but still a bargain!

No such thing as the perfect trade but well done for locking in profits. Sounds like you guys have read this pretty well.

I have a vague recollection that this board was amongst the best places to learn, chat and share about Scancell…

How did it ever become a place to air one’s woahs with the world and political bun fighting? Watching too much news I suppose will do it, and with nobody in the real world wishing to put up with such views alas, it is spamming this board. Surprised nobody is blaming Djokovic! Or maybe Clifford the big red dog? Mr Blobby always looked a suspicious character, maybe it’s all his fault.

Each to their own opinion of course.

Maybe have a good week of outstanding posts re our platforms and the wider issues that are related to our science we have to take the ruff with the smooth. The crap posts balance out the good ones.

Thanks, that gives me an entry point if I take the ARB option.

Still watching for safer price on FAR.

Markets spooked a little today.

lofas more likely they are looking to associate themselves with 2 businesses that are top 7 in the guardian…

But another mention for us does not hurt!

Dropped 10p, if it gets to 66p it’s time to top up!

Bitcoin below 40k

ARB dropped 20% in a week

Thoughts

Well done X! Can’t argue with profit large or small ;-)

If this hits .88 I will bag 33%. Then buy it again when it drops ;-)

Fingers crossed for you

Thanks for that Sparkington. We are trying to do an in-depth research on IQAI on the ODTT board. Any perspective on that period would be helpful.

Angle have shown great commercial acumen with contracts for labs so it should bode well when FDA comes through.

Whatever happened to Stonechecker! (Kidney stone diagnostic) It got FDA approval in the end and I see £238k reported in revenue. I wonder how much is down to which platform…

Quite a few people involved with IB & IQAI look quite impressive.

As I understand it, no two cancers are the same. So in several cases of breast cancer for example (cancer type), each patient would require bespoke treatment and drugs. To be absolutely clear, not all patients respond to the same drugs in the same way. This leads to a wide range of outcomes if treatment is not tailored correctly. So that would mean even within one cancer type each cancer is different.

Now as you may have guessed. I am not a scientist or physician. So having heard this view from another CEO of a cancer analyst investment it has made me think.

1. How accurate is this statement? In general terms.
2. If this is accurate, how good is SCIB1? Considering it’s outstanding performance phase 1/2.

https://www.scancell.co.uk/update-on-scib1-phase-12-clinical-trial

I have emailed Scancell with this question to see if they are able to guide my understanding of this in some way.

Funny I was researching IQAI last evening (very murky and ambiguous history for this company I can tell you!) They applied to FDA for Stonechecker (510) and gained approval eventually. I found this letter from FDA on google. Again it’s not an easy read, full of what ifs and caveats. Just an example of FDA’s interaction with a company. This was before the pandemic.

https://www.accessdata.fda.gov/cdrh_docs/pdf19/K191530.pdf

The chief operating officer said that the standard time for a 510 application is 90 FDA working days from acceptance. Then if further information is requested the clock starts again, so another 90 FDA working days.

David Smith chief operating officer of Flying Brands?? Trevor Brown CEO of IQAI since 2015. Flying Brands became IQAI in 2019! Clear as mud this lol.

Not sure if you have seen this but the former CEO David Smith gives a good account of Flying Brands (IQAI)

https://youtu.be/BF9KRrMEYv8

A few steps are in order before a buy out IMO. All of these would underpin the investment and present more value.

1. Maybe a specialist investor such as Redmile, Vulpes, Amati etc would springboard this investment to the attention of the right kinda people.

2. A partnership with Mount Sinai (please please please!) I do realise we have significant working relationships with US hospitals but Sinai would be amazing.

In any case I would imagine a major fundraise would be in order to make IQAI attractive. Cash is so important for many reasons. Maybe several but that’s a good thing IMO.

I will admit I don’t fully understand this investment scientifically but when I saw it 2 years ago on proactive I was very impressed. FDA approval is already a big derisking factor. I did not know much about investing then and had never heard of TB. So I was to cautious to invest and missed the SP hike.

I think Sclp a way father down the road in terms of lining ducks up are concerned, but I would not bet against IQAI becoming a multi bagger over the coming year. Then it could take off for real in years to come.

Thanks for this Chester. It gives a depth and richness to the bulletin board that brand new thoughts and observations just can’t... Funny isn’t it, that the very science that is reasonably new to me and others was sitting here all the time! Luckily we still have crumbs & Co contributing here and that is very valuable to us all. When it comes to inananco, well he was one of a kind wasn’t he. Love him or hate him I think we all miss him some how. I was a fan for what it’s worth.

Lots to read over and digest. Just in time for Modi1 trial to begin.

I for one say, keep it coming.